Journals / Medeniyet Medical Journal / 2020 / Cilt: 35 - Sayı: 1

HIV Negatif İmmünokompetan Bir Hastada Nazal Plazmablastik Lenfoma

Nasal Plasmablastic Lymphoma in an HIV-Negative Immunocompetent Patient

Pages
71–74
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Tedavi sonrası 18. ayda yapılan pozitron emisyon tomografi (PET) taramasında tümör rekürrensi lehine bir bulgu gözlenmedi.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Plazmablastik lenfoma (PBL), genellikle insan immün yetmezlik virüsü (HIV) pozitif erkek hastaların veya immünsüpresif konakların oral kavitesinde görülen, diffüz büyük B-hücreli lenfomanın nadir ve agresif seyirli bir varyantıdır.
📊
Key Findings & Data:Hastaya tümörün endoskopik rezeksiyonu yapıldı ve 6 kür kemoterapi (hiperfraksiyone-CVAD) uygulandı.
💡
Conclusion & Impact:Tedavi sonrası 18. ayda yapılan pozitron emisyon tomografi (PET) taramasında tümör rekürrensi lehine bir bulgu gözlenmedi.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Plazmablastik lenfoma (PBL), genellikle insan immün yetmezlik virüsü (HIV) pozitif erkek hastaların veya immünsüpresif konakların oral kavitesinde görülen, diffüz büyük B-hücreli lenfomanın nadir ve agresif seyirli bir varyantıdır. Literatürde immünokompetan hastalarda HIV negatif PBL ile ilgili bildiriler oldukça sınırlıdır. Çalışmamızda HIV negatif ve immünokompetan bir kadın hastada oluşan nadir bir sinonazal PBL vakası sunduk. Hastaya tümörün endoskopik rezeksiyonu yapıldı ve 6 kür kemoterapi (hiperfraksiyone-CVAD) uygulandı. Tedavi sonrası 18. ayda yapılan pozitron emisyon tomografi (PET) taramasında tümör rekürrensi lehine bir bulgu gözlenmedi.

Özet

Plasmablastic lymphoma (PBL) is a rare and aggressive variant of diffuse large B-cell lymphoma predominantly in oral cavities of human immunodeficiency virus (HIV)-positive male patients or immunosuppressive hosts. Limited number of reports on HIV-negative PBL in immunocompetent patients are available in the literature. We reported an unusual case of sinonasal PBL which occurred in an HIV-negative and immunocompetent female patient. She underwent endoscopic removal of the tumor and completed 6 cycles of chemotherapy (hyperfractionated-CVAD). Any finding in favour of tumour recurrence was not observed in positron-emission tomography scan (PET-scan) performed 18 months after the treatment.

🔖

Cite This Article

SHAKRI, N. M., HUSAIN, S., ZAHED, F. D., TAN, G. C. (2020). HIV Negatif İmmünokompetan Bir Hastada Nazal Plazmablastik Lenfoma. Medeniyet Medical Journal, Cilt: 35 - Sayı: 1, 71–74. https://ajindex.com/articles/283199

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood. 1997
  2. 89(4):1413-20. [CrossRef] 2. Colomo L, Loong F, Rives S, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol. 2004
  3. 28(6):736-47. [CrossRef] 3. Castillo JJ, Bibas M, Miranda RN. The biology and treatment of plasmablastic lymphoma. Blood. 2015
  4. 125(15):2323- 30. [CrossRef] 4. Castillo JJ, Winer ES, Stachurski D, et al. Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma. Leuk Lymphoma. 2010
  5. 51(11):2047-53. [CrossRef] 5. Liu JJ, Zhang L, Ayala E, et al. Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: a single institutional experience and literature review. Leuk Res. 2011
  6. 35(12):1571-7. [CrossRef] 6. Saraceni C, Agostino N, Cornfield DB, Gupta R. Plasmablastic lymphoma of the maxillary sinus in an HIVnegative patient: a case report and literature review. Springerplus. 2013
  7. 2(1):142. [CrossRef] 7. Perkins JN, Chi AW, Patel NJ. Plasmablastic Lymphoma of the Nasal Septum. JAMA Otolaryngol Head Neck Surg. 2019. [CrossRef] 8. Laurent C, Gravelle P, Péricart S, et al. EBV infection promotes tumor infiltrating leucocyte and immune escape in plasmablastic lymphoma according to gene expression profiling. Hematological Oncology. 2017
  8. [CrossRef] 9. Acute lymphoblastic leukemia Ph-hyperCVAD part A and B/POMP treatment protocol, eviQ cancer treatment protocols, in: https://www.eviq.org.au/ haematology-and-bmt/leukaemias/acute-lymphoblastic-leukaemia/788-ph-hyper-cvad-part-a-and-bpomp-treatment-ove#114306 [20 May 2016] 10. Philip T, Guglielmi C, Hagenbeek A, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapysensitive non-Hodgkin’s lymphoma. N Engl J Med. 1995
  9. 333(23):1540-5. [CrossRef]